Clinical Second-Pass Review

Quarter Overview

💵 Revenue at Risk — Documentation Gaps interventions likely performed but not charted (downcode / denial risk)

Enter Your Reimbursement Rates

ALS level reimbursement ($/transport)

BLS level reimbursement ($/transport)

Downcode / denial risk applied35%

Per affected claim: $200 · documentation-gap calls: 0

estimated revenue at risk this quarter

≈ $0 annualized

across documentation-gap flags only

Formula: documentation-gap calls × (ALS − BLS reimbursement) × risk%. Care-gap flags (intervention not delivered) are excluded — care that was not provided cannot be billed. Rates are yours to set; figures update live and save to this browser.

Rules That Produced No Finding — And Why

Agency Performance & Top Flags

Flagged Calls by Agency

High · Medium · Low priority

Top 5 Missed Interventions — System

Ranked by flag count this quarter

Agency Detail Table

Agency	Total Calls	Flagged	Flag Rate	High Priority	Medium	Low

Quarter-over-Quarter Trend

Quarter	Total Flagged	High Priority	Medium	Low	Flag Rate	QoQ Change

Clinical Second-Pass Review · Automated rule-based chart audit applied to all completed ePCRs · Rules cross-reference NEMSIS v3.5 elements: impression, vital signs, mechanism, procedures & medications documented · A flag does not confirm a missed intervention — it identifies cases for medical director review · Revenue at Risk is applied ONLY to documentation-gap flags (care performed but not charted → downcode/denial). Care-gap flags are clinical opportunities and are not billable · Revenue figures are estimates driven by user-entered reimbursement rates · Synthetic demonstration data — not real patients · NEMSIS v3.5